{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:50:29Z","timestamp":1767707429167,"version":"3.44.0"},"reference-count":34,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Viruses"],"abstract":"<jats:p>Thrombophilic conditions, conditions where blood has a tendency to form thrombi due to abnormal coagulatory processes, can affect the trajectory of diseases such as Post-Acute Sequelae of SARS-CoV-2 Infection, better known as Long COVID (LC), by worsening symptoms and complicating outlooks. As a comorbidity in pro-coagulatory diseases such as COVID-19 and LC, patients with thrombophilic conditions may experience worse symptoms than their peers, due to this elevated level of hypercoagulation. A 15-week literature review through the public PubMed database was conducted to investigate the severity, mechanisms, and symptom profiles of thrombophilic patients with LC. Papers were only included if samples included participants with pre-existing tendencies for hypercoagulable states, and confirmation of SARS-CoV-2 infection via a Polymerase Chain Reaction test. Each paper included in this review was analyzed by topic and assessed for eligibility against the Joanna Briggs Institute\u2019s Critical Appraisal tool. Each paper was also assessed for biases. Results from the 6 papers included in this review showed that LC could be predicted following COVID-19 illness by a hypercoagulable blood profile, indicating that LC may be linked to chronic hypercoagulation and inflammation post-infection. Additionally, symptoms linked to microthrombi formation, such as hair loss, arrhythmia, and dizziness, were exhibited more frequently in patients with thrombophilia and\/or thrombophilic conditions, indicating that those with thrombophilic conditions may exhibit unique LC symptom profiles compared to healthy controls. This paper\u2019s research is preliminary and thus is limited in the strength of its findings; However, further research into LC and its interactions with co-morbidities like thrombophilic conditions would aid in the development of better treatment plans for patients, such as the usage of anticoagulants or screening for hypercoagulable blood profiles post-COVID-19 to assess patient risk.<\/jats:p>","DOI":"10.3390\/v17101315","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:00:32Z","timestamp":1759132832000},"page":"1315","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Symptomatology of Long COVID Associated with Inherited and Acquired Thrombophilic Conditions: A Systematic Review"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1004-4800","authenticated-orcid":false,"given":"Amelia Mae","family":"Heath","sequence":"first","affiliation":[{"name":"British International School of Chicago, South Loop, 161 W 9th St, Chicago, IL 60605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6658-502X","authenticated-orcid":false,"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,28]]},"reference":[{"key":"ref_1","unstructured":"Senst, B., Tadi, P., Basit, H., and Jan, A. (2025, June 26). Hypercoagulability, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538251\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.7326\/0003-4819-102-6-814","article-title":"The Hypercoagulable States","volume":"102","author":"Schafer","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"ref_3","unstructured":"Merschel, M. (2025, June 26). Blood Clot Risk Remains Elevated Nearly a Year After COVID-19. American Heart Association, 19 September 2022. Available online: https:\/\/www.heart.org\/en\/news\/2022\/09\/19\/blood-clot-risk-remains-elevated-nearly-a-year-after-covid-19."},{"key":"ref_4","unstructured":"Centers for Disease Control and Prevention (2025, June 26). Long COVID Basics. CDC, 11 July 2024, Available online: https:\/\/www.cdc.gov\/covid\/long-term-effects\/index.html."},{"key":"ref_5","unstructured":"Mayo Clinic (2025, June 26). COVID-19 (Coronavirus): Long-Term Effects. Mayo Clinic, 18 August 2020. Available online: https:\/\/www.mayoclinic.org\/diseases-conditions\/coronavirus\/in-depth\/coronavirus-long-term-effects\/art-20490351."},{"key":"ref_6","unstructured":"Yale Medicine (2025, June 26). Long COVID (Post-COVID Conditions, PCC). Yale Medicine. Available online: https:\/\/www.yalemedicine.org\/conditions\/long-covid-post-covid-conditions-pcc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2020.06.029","article-title":"The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management","volume":"194","author":"Diamond","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12933-023-02097-8","article-title":"Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: A link with diabetes mellitus","volume":"23","author":"Valencia","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s10067-022-06497-1","article-title":"SARS-CoV-2 infection and SLE: Endothelial dysfunction, atherosclerosis, and thrombosis","volume":"42","author":"Drabik","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hayden, M.R., and Tyagi, S.C. (2021). Impaired Folate-Mediated One-Carbon Metabolism in Type 2 Diabetes, Late-Onset Alzheimer\u2019s Disease and Long COVID. Medicina, 58.","DOI":"10.3390\/medicina58010016"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Loutsidi, N.E., Politou, M., Vlahakos, V., Korakakis, D., Kassi, T., Nika, A., Pouliakis, A., Eleftheriou, K., Balis, E., and Pappas, A.G. (2024). Hypercoagulable Rotational Thromboelastometry During Hospital Stay Is Associated with Post-Discharge DLco Impairment in Patients with COVID-19-Related Pneumonia. Viruses, 16.","DOI":"10.3390\/v16121916"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11239-024-02961-8","article-title":"Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity","volume":"57","author":"Okazaki","year":"2024","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"da Silva, R., de Sarges, K.M.L., Cantanhede, M.H.D., da Costa, F.P., Dos Santos, E.F., Rodrigues, F.B.B., de Nazar\u00e9 do Socorro de Almeida Viana, M., de Meira Leite, M., da Silva, A.L.S., and de Brito, M.T.M. (2023). Thrombophilia and Immune-Related Genetic Markers in Long COVID. Viruses, 15.","DOI":"10.3390\/v15040885"},{"key":"ref_15","unstructured":"Dean, L. (2025, August 14). Methylenetetrahydrofolate Reductase Deficiency. National Center for Biotechnology Information, 8 March 2012, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK66131\/."},{"key":"ref_16","unstructured":"GeneCards Database (2025, August 11). MTHFR Gene-GeneCards; MTHR Protein; MTHR Antibody. Genecards.org, 15 July 2025. Available online: https:\/\/www.genecards.org\/cgi-bin\/carddisp.pl?gene=MTHFR&keywords=MTHFR#function."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in Long COVID\/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/a-1878-9566","article-title":"Diabetes and COVID-19: Short- and Long-Term Consequences","volume":"54","author":"Steenblock","year":"2022","journal-title":"Horm. Metab. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCRESAHA.121.320460","article-title":"Vascular Dysfunction of COVID-19 Is Partially Reverted in the Long-Term","volume":"130","author":"Zanoli","year":"2022","journal-title":"Circ. Res."},{"key":"ref_20","first-page":"1","article-title":"Accelerated vascular ageing after COVID-19 infection: The CARTESIAN study","volume":"00","author":"Bruno","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_21","first-page":"594986","article-title":"Factor V Leiden and Inflammation","volume":"2012","author":"Aras","year":"2012","journal-title":"Thrombosis"},{"key":"ref_22","first-page":"1910","article-title":"Thrombophilia as a factor in increasing inflammation in COPD","volume":"60","author":"Abduganieva","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ramakrishnan, R.K., Kashour, T., Hamid, Q., Halwani, R., and Tleyjeh, I.M. (2021). Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.686029"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/jth.15004","article-title":"ISTH DIC subcommittee communication on anticoagulation in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kwaan, H.C., and Lindholm, P.F. (2021). The Central Role of Fibrinolytic Response in COVID-19\u2014A Hematologist\u2019s Perspective. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031283"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/0115701611390778250321130817","article-title":"Evidence for the Interplay between Inflammation and Clotting System in the Pathogenetic Chain of Pulmonary Embolism: A Potential Therapeutic Target to Prevent Multi-organ Failure and Residual Thrombotic Risk","volume":"23","author":"Buonacera","year":"2025","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_27","first-page":"e47","article-title":"Therapeutic Impact of Tocilizumab in the Setting of Severe COVID-19; an Updated and Comprehensive Review on Current Evidence","volume":"12","author":"Rezabakhsh","year":"2024","journal-title":"Arch. Acad. Emerg. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Regolo, M., Vaccaro, M., Sorce, A., Stancanelli, B., Colaci, M., Natoli, G., Russo, M., Alessandria, I., Motta, M., and Santangelo, N. (2022). Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients. J. Clin. Med., 11.","DOI":"10.3390\/jcm11082235"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Regolo, M., Sorce, A., Vaccaro, M., Colaci, M., Stancanelli, B., Natoli, G., Motta, M., Isaia, I., Castelletti, F., and Giangreco, F. (2023). Assessing Humoral Immuno-Inflammatory Pathways Associated with Respiratory Failure in COVID-19 Patients. J. Clin. Med., 12.","DOI":"10.20944\/preprints202305.0810.v1"},{"key":"ref_30","unstructured":"Cleveland Clinic (2025, August 01). Homocysteine: Levels, Tests, High Homocysteine Levels. Cleveland Clinic, 31 January 2025. Available online: https:\/\/my.clevelandclinic.org\/health\/articles\/21527-homocysteine."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Cristiana Iosef Matusa, A.M., and Victor Fraser, D.D. (2024). Endocrine dysregulation in COVID-19: Molecular mechanisms and insights. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1459724"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Blanchflower, D.G., and Bryson, A. (2023). Long COVID in the United States. PLoS ONE, 18.","DOI":"10.3386\/w30988"},{"key":"ref_33","unstructured":"The Centers for Disease Control and Prevention (2025, June 26). People with Certain Medical Conditions and COVID-19 Risk Factors. CDC, 15 July 2024, Available online: https:\/\/www.cdc.gov\/covid\/risk-factors\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html."},{"key":"ref_34","unstructured":"The National Heart, Lung, and Blood Institute (2025, June 26). COVID-19 and the Blood. NHLBI, 20 December 2024, Available online: https:\/\/www.nhlbi.nih.gov\/covid\/blood."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/10\/1315\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:06:08Z","timestamp":1759133168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/10\/1315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,28]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["v17101315"],"URL":"https:\/\/doi.org\/10.3390\/v17101315","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,28]]}}}